As the Executive Director of The Myositis Association (TMA), Paula Eichenbrenner is at the forefront of a pivotal movement in the realm of myositis research, patient advocacy, and support. With a profound commitment to transforming the landscape for those affected by this rare autoimmune disease,...
As the Executive Director of The Myositis Association (TMA), Paula Eichenbrenner is at the forefront of a pivotal movement in the realm of myositis research, patient advocacy, and support. With a profound commitment to transforming the landscape for those affected by this rare autoimmune disease, Paula leverages her extensive expertise in public affairs, brand management, and strategic communication to elevate the organization’s mission. Under her leadership, TMA is not only enhancing its reputation but also expanding its reach to better serve patients and their families.
Paula’s role encompasses a diverse array of key projects aimed at fostering community engagement and advancing research initiatives. She is instrumental in developing programs that provide vital resources and support networks for individuals living with myositis. By prioritizing volunteer management and philanthropy, Paula ensures that TMA is well-equipped to implement impactful projects that resonate with the community. Her strategic oversight of budgets and program development has led to innovative fundraising campaigns that enhance the organization’s capacity to drive change.
In addition to her operational responsibilities, Paula is dedicated to advocating for policy changes that benefit patients, collaborating with healthcare professionals, researchers, and other stakeholders to amplify the voice of the myositis community. Her passion for community development and her ability to forge meaningful relationships are key to TMA’s success in creating a supportive environment for those navigating the challenges of myositis. With a vision grounded in empathy and empowerment, Paula Eichenbrenner is truly transforming the nonprofit landscape for myositis patients and their families.
